SOURCES SOUGHT
66 -- Equipment for Microdialysis
- Notice Date
- 8/4/2014
- Notice Type
- Sources Sought
- NAICS
- 334613
— Blank Magnetic and Optical Recording Media Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- 1133434
- Archive Date
- 8/23/2014
- Point of Contact
- Virginia C. House, Phone: 8705437405
- E-Mail Address
-
virginia.house@fda.hhs.gov
(virginia.house@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION Part I: General Information (Introduction/Background/Scope) The U.S. Food and Drug Administration (FDA) is conducting market research to support the requirement for an "in vivo microdialysis system that is capable of collecting neurotransmitters from the brains of freely moving rats. This equipment is essential to promote the scientific development process, and to study the behavioral and neurochemical changes of tobacco constituents in animal. The associated North American Industry Classification System (NAICS) Code is 334516 Analytical Laboratory Instrument Manufacturing, the Small Business Size Standard is 500 employees. Part II Technical Requirements A. The system must have key requirements and parts as follows: Equipment for microdialysis: • Four (4) Animal plastic bowls for post-surgery animal recovery • Four (4) Syringe pumps (or two (2) pumps allowing two (2) syringes to work at the same time) • A (1) surgical stereotaxic frame for rats (including a (1) manipulator/tower and two (2) 45 degrees ear bars for small animals • Two (2) Probe holder clips with connector rod and stereotaxic adapter • A (1) complete bone micro-drill system with accessory kit • Six (6) dedicated micro-syringes (1mL). • Four (4) Counter balanced arms designed to minimize behavioral disturbance on microdialysis probes and to allow the animal to move spontaneously. • Four (4) Stainless steel swivels to be connected to the counter balanced arms and to the probe. Must minimize dead volumes and reactivity with neurotransmitters. • A (1) Microtome system for general histological brain sectioning and for verifying the position of microdialysis probe placement. Fully equipped with sapphire blade, slicer kit and optic lamp. Microtome or tissue slicer must have a refrigerator. • Micro-camera for histology magnification and electric pictures. Consumables (up to 1 year): • Eighty (80) Concentric microdialysis probes. Probes must have 14mm shaft and 2 mm membrane length. Membrane must be made of cuprophane or regenerated cellulose with a maximum cut-off of 6kDa. • A (1) central nervous system (CNS) sterile perfusion fluid [Ringer solution or artificial cerebral spinal fluid (aCSF)] package • Two (2) Fluorinated ethylene propylene (FEP) tubings • A (1) Tubing adapter package Other mandatory requirements: • Installation and training • One (1) year warranty B. Deliverables Microdialysis equipment meeting technical requirements listed above. C. Service: Full One Year Warranty including parts and labor and four (4) one year options for post warranty preventive and corrective maintenance. D. Delivery Address: Food and Drug Administration National Center for Toxicological (NCTR) Division of Neurotoxicology 3900 NCTR Road Jefferson, AR 72079 Part III: Instructions to Prospective Respondents Responses to this sources sought shall unequivocally demonstrate that respondent has instruments capable of meeting technical requirements for the intended purposes discussed above. Though the target audience is small businesses capable of providing these items, all interested parties may respond. At a minimum, responses shall include the following: • Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; • Past performance information for sales of comparable instruments, used in comparable research, to include description (technical literature and specifications), dollar value, client name, address, point of contact (POC), POC phone number and email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; • Descriptive literature, brochures, specifications, marketing material, etc. detailing the nature of products the responding firm is regularly engaged in providing. • If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; • Although this is not a request for quote, informational pricing is encouraged; • The Government encourages any comments and/or suggestions from any interested party regarding this requirement. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested Parties must respond with capability statements which are due in person, by postal mail or email to the point of contact listed below on or before August 08, 2014 by 1:00 PM (Central Time) at the Food and Drug Administration, FDA/OO/OFBA/OAGS/DAP ATTN: Virginia C. House, 3900 NCTR Road, Bldg 50/Room 432, HFT‐320, Jefferson, AR 72079‐9502 or email virginia.house@fda.hhs.gov. Reference #1133021 in all correspondence with the point of contact listed above. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether this requirement should be set aside for small business, made available to full and open competition or procured through other than full and open acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis/solicitation (No. 1131231) may be published via FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/1133434/listing.html)
- Place of Performance
- Address: Food and Drug Administration, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, Arkansas, 72079, United States
- Zip Code: 72079
- Zip Code: 72079
- Record
- SN03448322-W 20140806/140804234514-f8700789b1fd7fed4201747002973b6a (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |